相似文献
1
Thymosin for immunodeficiency diseases and cancer.
Compr Ther. 1978 Feb;4(2):49-57.
2
Immunologic reconstitution of patients with primary immunodeficiency diseases and cancer after treatment with thymosin.
Transplant Proc. 1977 Mar;9(1):1141-4.
3
Thymosin: basic properties and clinical application in the treatment of immunodeficiency diseases and cancer.
Recent Results Cancer Res. 1980;75:100-5. doi: 10.1007/978-3-642-81491-4_16.
4
[Regular trisomy 21 and combined immunodeficiency. Ineffectiveness of thymosin].
Minerva Pediatr. 1979 Dec 15;31(23):1691-7.
5
Thymosin treatment of children with primary immunodeficiency disease.
Transplant Proc. 1978 Mar;10(1):203-9.
6
Overview of thymosin activity.
Cancer Treat Rep. 1978 Nov;62(11):1731-7.
7
Thymosin: basic properties and clinical potential in the treatment of patients with immunodeficiency diseases and cancer.
Antibiot Chemother (1971). 1978;24:47-59. doi: 10.1159/000401500.
8
The Gordon Wilson lecture. The history of the development of thymosin: chemistry, biology and clinical applications.
Trans Am Clin Climatol Assoc. 1977;88:79-94.
9
In vitro and in vivo enhancement of mixed lymphocyte culture reactivity by thymosin in patients with primary immunodeficiency disease.
Ann N Y Acad Sci. 1979;332:128-34. doi: 10.1111/j.1749-6632.1979.tb47106.x.
10
Research with immunoactive agents.
JAMA. 1981 Jul 17;246(3):205. doi: 10.1001/jama.1981.03320030007006.
引用本文的文献
1
Translation of mRNA from calf thymus in the wheat germ system: evidence for a precursor of thymosin alpha1.
Proc Natl Acad Sci U S A. 1978 Dec;75(12):6007-11. doi: 10.1073/pnas.75.12.6007.
Zotero 插件